Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.
Droplet-based single-cell analysis systems provide an invaluable tool to accelerate research and development. Recent scientific advances enhance the applicability of these droplet-based systems to address the age-old problem of characterising, understanding and selecting cells
The pharmaceutical industry is seeking new ways to accelerate the drug development process, to generate both time and cost savings. How is nuclear magnetic resonance spectroscopy helping to improve the drug development sector?
rAAV vectorology is being optimised to allow for highly specific expression and greater efficacy – how is this being achieved, and why is it so important?
Recent developments in gene therapy and the approval of mrna vaccines for treating diseases has seen the biopharmaceutical industry’s need for more well-characterised rna and oligonucleotides than ever before. How are more nucleic acid sequences being analysed by mass spectrometry (ms) through the development of new technologies, and how can innovations in software process data fully automate the workflow of the confirmation of oligonucleotide sequences based on intact ms/ms
IPT sat down with Dr Chris Vincent at PDD, to understand more about the digital innovations that are leading design and whether technologies like Extended Reality (XR) can be beneficial to the process
As technology within the analysis sphere continues to evolve, temperature control is becoming increasingly important for drug discovery and research
Concierge services are critical to helping patients navigate technology and other logistics in a decentralised clinical trial. How best can they be implemented?